Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Romanian Journal of Internal Medicine

4 Issues per year

Open Access
Online
ISSN
2501-062X
See all formats and pricing
More options …

Pulmonary veno-occlusive disease: a rare cause of pulmonary hypertension in systemic sclerosis. Case presentation and review of the literature

Ana Maria Daraban
  • Clinical Emergency Hospital Bucharest, Romania
  • “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Roxana Enache / L. Predescu / P. Platon / T. Constantinescu
  • “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • “Prof. Dr. Marius Nasta” Pneumology Institute, Bucharest, Romania
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Carina Mihai
  • “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • “Cantacuzino” Clinical Hospital, Bucharest, Romania
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ I.M. Coman
  • “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • “C.C. Iliescu” Emergency Institute for Cardiovascular Diseases, Bucharest, Romania
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Carmen Ginghină
  • “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • “C.C. Iliescu” Emergency Institute for Cardiovascular Diseases, Bucharest, Romania
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Ruxandra Jurcuţ
  • Corresponding author
  • “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • “C.C. Iliescu” Emergency Institute for Cardiovascular Diseases, Bucharest, Romania
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2015-10-14 | DOI: https://doi.org/10.1515/rjim-2015-0024

Abstract

Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary arterial hypertension (PAH). Because of the similar clinical picture of dyspnea on exertion and signs of right heart failure, PVOD is difficult to distinguish from idiopathic PAH. However, the distinction is mandatory because PVOD has a worse prognosis and, more importantly, the administration of PAH specific therapy (vasodilators) can precipitate severe acute pulmonary oedema. We present a challenging case of PAH in a patient with systemic sclerosis in whom a marked decrease in functional capacity after the initiation of bosentan therapy led to the diagnosis of PVOD. Management of PVOD patients is challenging and referral for lung transplantation should be done at the moment of diagnosis.

Boala pulmonară veno-ocluzivă (BPVO) este o cauză rară de hipertensiune arterială pulmonară (HTP). Datorită aspectului similar clinic îmbrăcat de BPVO şi de HTP idiopatică caracterizate prin dispnee de efort şi semne ale insuficienţei cardiace drepte, cele două entităţi sunt dificil de diferenţiat. Totuşi, distincţia dintre cele două este obligatorie deoarece BPVO prezintă un prognostic mai prost decât HTP idiopatică şi, mai important, administrarea terapiei specifice pentru HTP (vasodilatatoare) poate precipita edemul pulmonar acut sever. Este prezentat un caz interesant al unei paciente diagnosticată cu sclerodermie sistemică la care diagnosticul de BPVO a fost realizat după ce capacitatea sa pulmonară s-a degradat după iniţierea terapiei cu bosentan. Managementul pacienţilor cu BPVO reprezintă o provocare şi trimiterea către transplant pulmonar ar trebui realizată odată cu punerea diagnosticului.

Keywords: Pulmonary arterial hypertension; pulmonary venoocclusive disease; Systemic sclerosis

REFERENCES

  • 1. SIMONNEAU G, GATZOULIS MA, ADATIA I, CELERMAJER D, DENTON C, GHOFRANI A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013;62:D34–41.CrossrefGoogle Scholar

  • 2. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal 2009; 30:2493–2537.Google Scholar

  • 3. MONTANI D, PRICE LC, DORFMULLER P, ACHOUH L, JAÏS X, YAÏCI A, et al. Pulmonary veno-occlusive disease. Eur Respir J 2009; 33: 189–200.CrossrefGoogle Scholar

  • 4. MORASSUT PA, WALLEY VM, SMITH CD. Pulmonary veno-occlusive disease and the CREST variant of scleroderma. Can J Cardiol. 1992;8(10):1055-1058.Google Scholar

  • 5. ZHANG L, VISSCHER D, RIHAL C, AUBRY MC. Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease. Rheumatol Int 2007; 27: 1163–1165.CrossrefGoogle Scholar

  • 6. HOURSEAU M, CAPRON F, NUNES H, GODMER P, MARTIN A, KAMBOUCHNER M. Pulmonary veno-occlusive disease in a patient with HIV infection. A case report with autopsy findings. Ann Pathol. 2002;22(6):472-475.Google Scholar

  • 7. WILLIAMS LM, FUSSELL S, VEITH RW, NELSON S, MASON CM. Pulmonary veno-occlusive disease in an adult following bone marrow transplantation. Case report and review of the literature. Chest 1996; 109: 1388–1391.CrossrefGoogle Scholar

  • 8. SEGUCHI M, HIRABAYASHI N, FUJII Y, et al. Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. Transplantation 2000; 69: 177–179.CrossrefGoogle Scholar

  • 9. NUNES H, HUMBERT M, CAPRON F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, hemodynamics and prognosis. Thorax 2006; 61: 68–74. 31CrossrefGoogle Scholar

  • 10. FARTOUKH M, HUMBERT M, CAPRON F, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000; 161: 216–223.Google Scholar

  • 11. KHANNA D. Diagnosis and treatment of systemic and localized scleroderma. Expert Rev. Dermatol. 2011; 6(3):287–302.CrossrefGoogle Scholar

  • 12. CHAISSON NF, HASSOUN PM. Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. CHEST 2013; 144(4): 1346–1356.CrossrefGoogle Scholar

  • 13. LAMBOVA S. Cardiac manifestations in systemic sclerosis. World J Cardiol 2014 26; 6(9): 993-1005.CrossrefGoogle Scholar

  • 14. KHANNA D, GLADUE H, CHANNICK R, CHUNG L, DISTLER O, FURST DE, et al. Recommendations for Screening and Detection of Connective-Tissue Disease Associated Pulmonary Arterial Hypertension. Arthritis Rheum. 2013; 65(12): 3194-201.CrossrefGoogle Scholar

  • 15. MONTANI D, O’CALLAGHAN DS, SAVALE L, JAÏS X, YAÏCI A, MAITRE S, et al. Pulmonary veno-occlusive disease: Recent progress and current challenges. Respiratory Medicine. 2010; 104:S23eS32.Web of ScienceCrossrefGoogle Scholar

  • 16. HORA J. Zur Histologie der klinischen “primaren Pulmonalsklerose”. Frankfurt Z Pathol. 1934; 47:100-08.Google Scholar

  • 17. RUNO JR, VNENCAK-JONES CL, PRINCE M, et al. Pulmonary venoocclusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. Am J Respir Crit Care Med 2003; 167(6):889e94.Google Scholar

  • 18. GAGNADOUX F, CAPRON F, LEBEAU B. Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma. Lung Cancer 2002; 36(2):213e5.CrossrefGoogle Scholar

  • 19. JOSELSON R, WARNOCK M. Pulmonary veno-occlusive disease after chemotherapy. Hum Pathol. 1983; 14(1):88-91.CrossrefGoogle Scholar

  • 20. LOMBARD CM, CHURG A, WINOKUR S. Pulmonary veno-occlusive disease following therapy for malignant neoplasms. Chest. 1987; 92(5):871-876.CrossrefGoogle Scholar

  • 21. MONTANI D, ACHOUH L, DORFMULLER P, et al. Pulmonary venoocclusive disease: Clinical, functional, radiologic, hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore) 2008; 87: 220–233.Web of ScienceCrossrefGoogle Scholar

  • 22. KRAMER MR, ESTENNE M, BERKMAN N, ANTOINE M, DE FRANCQUEN P, LIPSKI A, et al. Radiation-induced pulmonary veno-occlusive disease. Chest. 1993; 104(4):1282-1284.CrossrefGoogle Scholar

  • 23. JOHNSON SR, PATSIOS D, HWANG DM, GRANTON JT. Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension. J Rheumatol 2006; 33:2347–2350.Google Scholar

  • 24. LANTUEJOUL S, SHEPPARD MN, CORRIN B, BURKE MM, NICHOLSON AG. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases. Am J Surg Pathol 2006; 30: 850–857.Google Scholar

  • 25. DORFMULLER P, HUMBERT M, PERROS F, et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 2007; 38: 893–902.Web of ScienceCrossrefGoogle Scholar

  • 26. NICOD P, MOSER KM. Primary pulmonary hypertension. The risk and benefit of lung biopsy. Circulation.1989; 80(5): 1486-1488.CrossrefGoogle Scholar

  • 27. PALMER SM, ROBINSON LJ, WANG A, GOSSAGE JR, BASHORE T, TAPSON VF. Massive pulmonary oedema and death after prostacyclin infusion in a patient with pulmonary venoocclusive disease. Chest 1998; 113: 237–240.CrossrefGoogle Scholar

  • 28. CREAGH-BROWN BC, NICHOLSON AG, SHOWKATHALI R, GIBBS JS, HOWARD LS. Pulmonary veno-occlusive disease presenting with recurrent pulmonary oedema and the use of nitric oxide to predict response to sildenafil. Thorax 2008; 63: 933–934.Web of ScienceCrossrefGoogle Scholar

  • 29. GUPTA R. Pulmonary function test as screening test for pulmonary artery hypertension in scleroderma patients. Rheumatology. 2004; 43(10): 1315.CrossrefGoogle Scholar

  • 30. RABILLER A, JAIS X, HAMID A, et al. Occult alveolar haemorrhage in pulmonary veno-occlusive disease. Eur Respir J 2006; 27: 108–113.CrossrefGoogle Scholar

  • 31. GŰNTHER S, JAĎS X, MAITRE S, BÉREZNÉ A, DORFMŰLLER, SEFERIAN A, et al. Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension. Arthritis Rheum. 2012; 64(9):2995–3005.CrossrefGoogle Scholar

  • 32. MEYER KC, RAGHU G, BAUGHMAN RP, BROWN KK, COSTABEL U, DU BOIS RM, et al. An official american thoracic society clinical practice guideline: The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 185(9):1004–1014.Web of ScienceGoogle Scholar

  • 33. D. MONTANI, X. JAÏS, P. DORFMULLER, G. SIMONNEAU, O. SITBON, M. HUMBERT. Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution. ERJ 2009; 34 (5):1204-1206.CrossrefGoogle Scholar

About the article

Published Online: 2015-10-14

Published in Print: 2015-06-01


Citation Information: Romanian Journal Of Internal Medicine, ISSN (Online) 1220-4749, DOI: https://doi.org/10.1515/rjim-2015-0024.

Export Citation

© 2015 Ana Maria Daraban et al., published by De Gruyter Open. This chapter is distributed under the terms of the Creative Commons Attribution 4.0 Public License. BY 4.0

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Reactions Weekly, 2015, Volume 1581, Number 1, Page 66

Comments (0)

Please log in or register to comment.
Log in